439 related articles for article (PubMed ID: 33716975)
21. Parathyroid hormone release in vitro in hyperparathyroidism associated with multiple endocrine neoplasia type 1.
Benson L; Rastad J; Ljunghall S; Rudberg C; Akerström G
Acta Endocrinol (Copenh); 1987 Jan; 114(1):12-7. PubMed ID: 2880443
[TBL] [Abstract][Full Text] [Related]
22. Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.
Marx SJ; Goltzman D
J Bone Miner Res; 2019 Jan; 34(1):22-37. PubMed ID: 30536424
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
[TBL] [Abstract][Full Text] [Related]
25. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
[TBL] [Abstract][Full Text] [Related]
26. [Surgical treatment of hyperparathyroidism].
Târcoveanu E; Niculescu D; Moldovanu R; Cotea E; Vasilescu A; Dănilă N; Lăzescu D; Ferariu D; Crumpei F; Ichim M; Zbranca E
Chirurgia (Bucur); 2009; 104(5):531-44. PubMed ID: 19943551
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics of primary and secondary hyperparathyroidism.
Dotzenrath C; Goretzki PE; Farnebo F; Teh BT; Weber G; Röher HD; Larsson C
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():105-7. PubMed ID: 8981014
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature.
Christakis I; Busaidy NL; Cote GJ; Williams MD; Hyde SM; Silva Figueroa AM; Kwatampora LJ; Clarke CN; Qiu W; Lee JE; Perrier ND
Int J Surg; 2016 Jul; 31():10-6. PubMed ID: 27212590
[TBL] [Abstract][Full Text] [Related]
30. Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism.
Wallfelt C; Gylfe E; Larsson R; Ljunghall S; Rastad J; Akerström G
J Endocrinol; 1988 Mar; 116(3):457-64. PubMed ID: 3351432
[TBL] [Abstract][Full Text] [Related]
31. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
32. HRPT2- (CDC73) RELATED HEREDITARY HYPERPARATHYROIDISM: A CASE SERIES FROM WESTERN INDIA.
Khadilkar KS; Budyal SR; Kasliwal R; Lila AR; Bandgar T; Shah NS
Endocr Pract; 2015 Sep; 21(9):1010-6. PubMed ID: 26121439
[TBL] [Abstract][Full Text] [Related]
33. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
34. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.
Khosla S; Ebeling PR; Firek AF; Burritt MM; Kao PC; Heath H
J Clin Endocrinol Metab; 1993 Mar; 76(3):715-20. PubMed ID: 8445032
[TBL] [Abstract][Full Text] [Related]
35. Regulation of parathyroid hormone release in primary and secondary hyperparathyroidism - studies in vivo and in vitro.
Rudberg C; Akerström G; Ljunghall S; Grimelius L; Johansson H; Pertoft H; Wide L
Acta Endocrinol (Copenh); 1982 Nov; 101(3):408-13. PubMed ID: 7148339
[TBL] [Abstract][Full Text] [Related]
36. Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.
Sato K; Obara T; Yamazaki K; Kanbe M; Nakajima K; Yamada A; Yanagisawa T; Kato Y; Nishikawa T; Takano K
J Clin Endocrinol Metab; 2001 Nov; 86(11):5564-71. PubMed ID: 11701736
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathogenesis of primary hyperparathyroidism.
Cetani F; Pardi E; Borsari S; Marcocci C
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
[TBL] [Abstract][Full Text] [Related]
38. Familial parathyroid tumors: diagnosis and management.
Stålberg P; Carling T
World J Surg; 2009 Nov; 33(11):2234-43. PubMed ID: 19184636
[TBL] [Abstract][Full Text] [Related]
39. Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period.
Nakajima K; Umino K; Azuma Y; Kosaka S; Takano K; Obara T; Sato K
J Bone Miner Metab; 2009; 27(2):224-33. PubMed ID: 19194773
[TBL] [Abstract][Full Text] [Related]
40. P53 tumour suppressor gene expression in hyperparathyroidism.
Subramaniam P; Wilkinson S; Shepherd JJ
Aust N Z J Surg; 1996 May; 66(5):302-4. PubMed ID: 8634048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
